BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18565351)

  • 1. [Radiotherapy of adult glial tumors: new developments and perspectives].
    Maire JP; Huchet A; Catry-Thomas I
    Rev Neurol (Paris); 2008; 164(6-7):531-41. PubMed ID: 18565351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of radiotherapy in recurrent gliomas].
    Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
    Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
    Chang JE; Khuntia D; Robins HI; Mehta MP
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in the treatment of malignant gliomas.
    Soffietti R; Leoncini B; Rudà R
    Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study.
    Dally M; Rosenthal M; Drummond K; Murphy M; Cher L; Ashley D; Thursfield V; Giles G
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):318-24. PubMed ID: 19624300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult].
    Mazeron JJ; Simon JM; Noël G; Proudhom MA; Renard A
    Cancer Radiother; 2000 Nov; 4 Suppl 1():53s-66s. PubMed ID: 11194965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation oncology in brain tumors: current approaches and clinical trials in progress.
    Chan MD; Tatter SB; Lesser G; Shaw EG
    Neuroimaging Clin N Am; 2010 Aug; 20(3):401-8. PubMed ID: 20708554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern aspects of radiation therapy for glial tumours of the brain.
    Rampling R
    Forum (Genova); 1998; 8(3):289-301. PubMed ID: 9755293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrogliomas: molecular biology and treatment.
    Bromberg JE; van den Bent MJ
    Oncologist; 2009 Feb; 14(2):155-63. PubMed ID: 19182242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in radiation therapy for brain tumors.
    Stieber VW; Mehta MP
    Neurol Clin; 2007 Nov; 25(4):1005-33, ix. PubMed ID: 17964024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status.
    Fathi AR; Vassella E; Arnold M; Curschmann J; Reinert M; Vajtai I; Weis J; Deiana G; Mariani L
    Strahlenther Onkol; 2007 Sep; 183(9):517-22. PubMed ID: 17762927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].
    Laprie A
    Cancer Radiother; 2009 Oct; 13(6-7):556-61. PubMed ID: 19766525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate analysis of the prognostic factors of grade III gliomas.
    Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
    Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.